Every finished drug product is built around one core component: the substance that actually produces the therapeutic effect. Here’s what an API is, why sourcing it correctly is a regulatory as much as a commercial decision, and what to check before qualifying a supplier.
What Is an API?
An Active Pharmaceutical Ingredient (API) is the biologically active substance in a drug product responsible for its therapeutic effect — as distinct from excipients, which are the inactive substances (binders, fillers, coatings) that make up the rest of the formulation. When a tablet, injectable, or capsule is manufactured, the API is combined with excipients to create the finished dosage form.
APIs can be manufactured via chemical synthesis, fermentation, extraction from natural sources, or biotechnology processes, depending on the molecule.
Why API Sourcing Is a Regulatory Decision, Not Just a Commercial One
Because the API determines a drug’s safety and efficacy, regulators scrutinize API sourcing closely. Every API used in a regulated drug product needs to be traceable to a qualified, GMP-compliant manufacturing source, typically documented through a Drug Master File (DMF) or equivalent regulatory filing. Switching API suppliers — even to an equally qualified one — usually requires regulatory notification or approval, which is why supplier qualification needs to happen well before a supply disruption forces the issue.
What to Check Before Qualifying an API Supplier
- GMP compliance — current certification and inspection history for the specific manufacturing site
- DMF status — an active, referenceable Drug Master File for the API in your target market
- Impurity profile documentation — particularly critical for oncology and other high-risk therapeutic categories
- Batch consistency data — evidence of reliable quality across multiple production batches
- Supply continuity track record — a supplier’s history of reliable delivery, not just a one-time qualification sample
How Chemigran Supports API Sourcing
Chemigran supplies pharmaceutical APIs, RLDs, and intermediates searchable by CAS number, backed by GMP documentation and batch traceability. For teams facing a supply disruption or qualifying a second API source, our team can help identify and validate a compliant alternative supplier without restarting the sourcing process from zero.
FAQ
What’s the difference between an API and an excipient?
The API is the biologically active ingredient responsible for the drug’s therapeutic effect. Excipients are the inactive components — fillers, binders, coatings — that make up the rest of the formulation.
Does changing an API supplier require regulatory approval?
In most jurisdictions, yes — a change in API source typically requires notification or approval from the relevant regulatory authority, since it can affect the drug’s approved manufacturing process.
What is a Drug Master File (DMF)?
A confidential regulatory filing submitted by an API manufacturer to authorities like the FDA, containing detailed manufacturing and quality information that drug product applicants can reference in their own submissions.
Sourcing or qualifying a new API supplier? Browse our API & RLD catalog or contact our team for supply continuity support.
